Periodic Reporting for period 2 - OPTOGENERAPY (Optogenetic Protein Therapy for Multiple Sclerosis)

Optogenerapy - Optogenetic Protein Therapy for Multiple Sclerosis- aims to develop and demonstrate a new optogenetics implant for controlled beta interferon (IFN-ß) protein delivery for treating Multiple Sclerosis patients, in a 3 years project funded by the European...